Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel G Cormier

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Virology|August 7, 2002
The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptorEmmanuel G Cormier, Tatjana Dragic
Journal of Virology|February 28, 2002
CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolatesDaniah A D Thompson, Emmanuel G Cormier, Tatjana Dragic
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
CD81 is an entry coreceptor for hepatitis C virusEmmanuel G Cormier, Fay Tsamis, Francis Kajumo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2004
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virusEmmanuel G Cormier, Robert J Durso, Fotini Tsamis, et al.
Journal of Virology|December 4, 2003
Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1Julie Dumonceaux, Emmanuel G Cormier, Francis Kajumo, et al.
The Journal of General Virology|August 9, 2006
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticlesEmilia Falkowska, Robert J Durso, Jason P Gardner, et al.
Virology|May 15, 2007
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanionsClaire Bertaux, Dirk Daelemans, Laurent Meertens, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Virology|August 7, 2002
The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptorEmmanuel G Cormier, Tatjana Dragic
Journal of Virology|February 28, 2002
CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolatesDaniah A D Thompson, Emmanuel G Cormier, Tatjana Dragic
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
CD81 is an entry coreceptor for hepatitis C virusEmmanuel G Cormier, Fay Tsamis, Francis Kajumo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2004
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virusEmmanuel G Cormier, Robert J Durso, Fotini Tsamis, et al.
Journal of Virology|December 4, 2003
Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1Julie Dumonceaux, Emmanuel G Cormier, Francis Kajumo, et al.
The Journal of General Virology|August 9, 2006
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticlesEmilia Falkowska, Robert J Durso, Jason P Gardner, et al.
Virology|May 15, 2007
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanionsClaire Bertaux, Dirk Daelemans, Laurent Meertens, et al.
Pageof 1